Cargando…
Protective Effects of Li-Fei-Xiao-Yan Prescription on Lipopolysaccharide-Induced Acute Lung Injury via Inhibition of Oxidative Stress and the TLR4/NF-κB Pathway
Li-Fei-Xiao-Yan prescription (LFXY) has been clinically used in China to treat inflammatory and infectious diseases including inflammatory lung diseases. The present study was aimed at evaluating the potential therapeutic effects and potential mechanisms of LFXY in a murine model of lipopolysacchari...
Autores principales: | Xu, Lie-Qiang, Yu, Xiu-Ting, Gui, Shu-Hua, Xie, Jian-hui, Wang, Xiu-Fen, Su, Zu-Qing, Li, Yu-Cui, Lai, Xiao-Ping, Zhan, Janis Ya-Xian, Xie, You-Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5382312/ https://www.ncbi.nlm.nih.gov/pubmed/28424738 http://dx.doi.org/10.1155/2017/1791789 |
Ejemplares similares
-
“Fei Yan No. 1” as a Combined Treatment for COVID-19: An Efficacy and Potential Mechanistic Study
por: Ai, Zhongzhu, et al.
Publicado: (2020) -
Investigation of target genes and potential mechanisms related to compound Xiao-ai-fei honey ointment based on network pharmacology and bioinformatics analysis
por: Abudurousuli, Kayisaier, et al.
Publicado: (2023) -
BuFeiXiaoJiYin ameliorates the NLRP3 inflammation response and gut microbiota in mice with lung cancer companied with Qi-yin deficiency
por: Jiang, Rui-yuan, et al.
Publicado: (2022) -
The immune-regulating effect of Xiao’er Qixingcha in constipated mice induced by high-heat and high-protein diet
por: Qu, Chang, et al.
Publicado: (2017) -
Confirmation of Leptobrachellaventripunctata (Fei, Ye, and Li, 1990), based on molecular and morphological evidence in Thailand
por: Wu, Yun-He, et al.
Publicado: (2021)